Contact us for free information or to start a free case review.
The Food and Drug Administration announced last week that all antidepressant labeling will be revised to highlight the increased risk of suicide in young adults
Antidepressants are currently required to carry a bold black box warning to alert patients to the risk of suicidal thoughts and behaviors in children and adolescents. The revised label will extend the age associated with the risk of suicidality to 25.
According to the FDA, various studies have consistently confirmed this risk, and as a result, the agency is giving antidepressant manufacturers 30 days to submit labeling revisions and create informative, easy-to-read patient Medication Guides.
In the meantime, the FDA is emphasizing the need for close monitoring and observation of patients under the age of 25 taking any antidepressant, particularly in the first one to two months of treatment.
All antidepressants, including Paxil , Prozac , Zoloft, Celexa, Effexor and Lexapro, will receive updated labeling. A more complete list of antidepressants is listed on the FDA website.
(Source: FDA website)
Injured by a defective drug? Ensure your legal rights are protected by contacting an experienced attorney near you today.Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.